Our study on the last resort antibiotic colistin was just accepted by Angew Chem. (bit.ly/4dF8q9n). We reduce its renal cell toxicity by a two-component strategy and bioorthogonal chemistry.
#chemicalbiology #antibiotics @helmholtz_hzi @_dzif @UniHannover
#chemicalbiology #antibiotics @helmholtz_hzi @_dzif @UniHannover